Harry Sokol - Saint-Antoine Hospital

Harry Sokol

Saint-Antoine Hospital

France

ORCID logohttps://orcid.org/0000-0002-2914-1822

Harry Sokol - Saint-Antoine Hospital

Harry Sokol

Introduction

Primary Affiliation: Saint-Antoine Hospital - France

Publications

293Publications

4585Reads

1Profile Views

1665PubMed Central Citations

Roux-en-Y Gastric-Bypass and sleeve gastrectomy induces specific shifts of the gut microbiota without altering the metabolism of bile acids in the intestinal lumen.

Int J Obes (Lond) 2019 02 30;43(2):428-431. Epub 2018 Jan 30.

Sorbonne Universités, UPMC Univ. Paris 06, École normale supérieure, PSL Research University, CNRS, INSERM, APHP, Laboratoire des Biomolécules (LBM), 27 rue de Chaligny, Paris, 75005, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41366-018-0015-3DOI Listing
February 2019
32 Reads
2 Citations
5.004 Impact Factor

Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome.

Cell Metab 2018 11 26;28(5):737-749.e4. Epub 2018 Jul 26.

Micalis Institute, Institut National de la Recherche Agronomique (INRA), AgroParisTech, Université Paris-Saclay, 78352 Jouy-en-Josas, France; Sorbonne Universités, UPMC Univ. Paris 06, École Normale Supérieure, CNRS, INSERM, APHP Laboratoire des Biomolécules (LBM), 27 rue de Chaligny, 75012 Paris, France; Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique - Hopitaux de Paris, UPMC, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2018.07.001DOI Listing
November 2018
41 Reads
17.570 Impact Factor

Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes.

Cell Metab 2018 10 12;28(4):557-572.e6. Epub 2018 Jul 12.

Institut Necker-Enfants Malades (INEM), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Sorbonne Universités, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2018.06.012DOI Listing
October 2018
4 Reads
17.570 Impact Factor

Aryl hydrocarbon receptor and intestinal immunity.

Mucosal Immunol 2018 07 7;11(4):1024-1038. Epub 2018 Apr 7.

Laboratoire de biomolécules, LBM, Sorbonne Université, École normale supérieure, PSL Research University, CNRS, INSERM, AP-HP, Hôpital Saint-Antoine, Paris, F-75005, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41385-018-0019-2DOI Listing
July 2018
2 Reads
1 Citation
7.374 Impact Factor

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease.

Cell Host Microbe 2018 06;23(6):716-724

INRA, UMR1319 Micalis & AgroParisTech, Jouy en Josas, France; Sorbonne Université, École normale supérieure, PSL Research University, CNRS, INSERM, AP-HP, Gastroenterology Department, Hôpital Saint-Antoine, Laboratoire de biomolécules, LBM, 184 rue du Faubourg Saint-Antoine, Paris 75005, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S19313128183025
Publisher Site
http://dx.doi.org/10.1016/j.chom.2018.05.003DOI Listing
June 2018
56 Reads
2 Citations
12.330 Impact Factor

Differences in epidemiological features between ulcerative colitis and Crohn's disease: The early life-programmed versus late dysbiosis hypothesis.

Med Hypotheses 2018 Jun 23;115:19-21. Epub 2018 Mar 23.

Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine F-75012 and UPMC Univ Paris 06, F-75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mehy.2018.03.009DOI Listing
June 2018
31 Reads
1.152 Impact Factor

Gut microbiota: Beyond metagenomics, metatranscriptomics illuminates microbiome functionality in IBD.

Nat Rev Gastroenterol Hepatol 2018 04 21;15(4):193-194. Epub 2018 Feb 21.

Sorbonne Université, École normale supérieure, PSL Research University, CNRS, INSERM, AP-HP, Hôpital Saint-Antoine, Laboratoire de biomolécules, LBM, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrgastro.2018.15DOI Listing
April 2018
1 Read
12.610 Impact Factor

A Versatile New Model of Chemically Induced Chronic Colitis Using an Outbred Murine Strain.

Front Microbiol 2018 27;9:565. Epub 2018 Mar 27.

Commensals and Probiotics-Host Interactions Laboratory, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2018.00565DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881104PMC
March 2018
3 Reads
3.941 Impact Factor

[Gut microbiota: What impact on colorectal carcinogenesis and treatment?]

Bull Cancer 2018 Jan 6;105(1):70-80. Epub 2017 Dec 6.

AP-HP, hôpital Saint-Antoine, service de gastro-entérologie et nutrition, 184, rue du faubourg Saint-Antoine, 75571 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.10.025DOI Listing
January 2018
49 Reads
0.640 Impact Factor

The microbiota: an underestimated actor in radiation-induced lesions?

Gut 2018 01 4;67(1):1-2. Epub 2017 May 4.

Department of Internal Medicine I, Medizinische Universitat Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2017-314279DOI Listing
January 2018
13 Reads
1 Citation
14.660 Impact Factor

Microbiota in digestive cancers: our new partner?

Carcinogenesis 2017 12;38(12):1157-1166

Department of Gastroenterology and Hepatology and Inserm U954, Nancy University Hospital, Lorraine University, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgx087DOI Listing
December 2017
16 Reads
5.334 Impact Factor

Probiotic Strain BL23 Prevents Colitis-Associated Colorectal Cancer.

Front Immunol 2017 17;8:1553. Epub 2017 Nov 17.

Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2017.01553DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702231PMC
November 2017
54 Reads
5 Citations

Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.

Ann Rheum Dis 2017 Sep 12;76(9):1614-1622. Epub 2017 Jun 12.

Micalis Institute, INRA, AgroParisTech, Université ParisSaclay, Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-211064DOI Listing
September 2017
80 Reads
11 Citations
10.380 Impact Factor

[The gut microbiota, a new cardiovascular risk factor?]

Presse Med 2017 Jul - Aug;46(7-8 Pt 1):708-713. Epub 2017 Jul 26.

AP-HP, hôpital Saint-Antoine, service de gastro-entérologie et nutrition, 75012 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2017.06.005DOI Listing
September 2017
5 Reads
1 Citation
1.173 Impact Factor

New Insights into the Diversity of the Genus .

Front Microbiol 2017 22;8:1790. Epub 2017 Sep 22.

Department of Immunology, Microbiology and Parasitology, Institute of Biological Sciences and Natural Sciences, Federal University of Triângulo MineiroUberaba, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2017.01790DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609107PMC
September 2017
139 Reads
4 Citations
3.941 Impact Factor

Using murine colitis models to analyze probiotics-host interactions.

FEMS Microbiol Rev 2017 08;41(Supp_1):S49-S70

INRA, Commensals and Probiotics-Host Interactions Laboratory, Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, 78350 Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/femsre/fux035DOI Listing
August 2017
9 Reads
3 Citations
13.244 Impact Factor

Caspase recruitment domain 9, microbiota, and tryptophan metabolism: dangerous liaisons in inflammatory bowel diseases.

Curr Opin Clin Nutr Metab Care 2017 Jul;20(4):243-247

aSorbonne University-Pierre and Marie Curie University bINSERM ERL 1157, Avenir Team Gut Microbiota and Immunity cCNRS UMR 7203 dLaboratoire de BioMolécules (LBM), CHU Saint-Antoine eMicalis Institute, INRA, Agro Paris Tech, Université Paris-Saclay, Jouy-en-Josas fInflammation-Immunopathology-Biotherapy Department (DHU i2B) gDepartment of Gastroenterology, Saint Antoine Hospital, Assistance Publique-Hopitaux de Paris, Pierre and Marie Curie University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCO.0000000000000382DOI Listing
July 2017
45 Reads
1 Citation
3.990 Impact Factor

One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Vuitton L, OBSERV-IBD study group and the GETAID, Alimentary pharmacology & therapeutics, 20

http://europepmc.org/abstract/med/28593685

View Article
July 2017

Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.

Breban M, Tap J, Leboime A, Said-Nahal R, Langella P, Chiocchia G, Furet JP, Sokol H, Annals of the rheumatic diseases, 2017, 2017

http://europepmc.org/abstract/med/28606969

View Article
July 2017

Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.

Dig Liver Dis 2017 Jun 30;49(6):643-646. Epub 2017 Jan 30.

Department of Gastroenterology, Saint Antoine Hospital, AP-HP, and GRC-UPMC 03, UPMC University Paris 06, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2017.01.162DOI Listing
June 2017
37 Reads
1 Citation
2.963 Impact Factor

Functional Characterization of Novel Strains Isolated from Healthy Volunteers: A Step Forward in the Use of as a Next-Generation Probiotic.

Front Microbiol 2017 30;8:1226. Epub 2017 Jun 30.

Commensals and Probiotics-Host Interactions Laboratory, Micalis Institute, Institut National de la Recherche Agronomique, AgroParisTech, Université Paris-SaclayJouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2017.01226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5492426PMC
June 2017
169 Reads
12 Citations
3.941 Impact Factor

Fecal Microbiota Transplantation: Do We Need Harmonization?

Clin Infect Dis 2017 05;64(9):1292

French Group of Faecal Microbiota Transplantation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/cix092DOI Listing
May 2017
39 Reads
8.890 Impact Factor

A microbial signature for Crohn's disease.

Gut 2017 05 7;66(5):813-822. Epub 2017 Feb 7.

Department of Gastroenterology, Vall d'Hebron Research Institute, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2016-313235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531220PMC
May 2017
62 Reads
20 Citations
14.660 Impact Factor

Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France.

Dunogué B, Pilmis B, Mahlaoui N, Elie C, Coignard-Biehler H, Amazzough K, Noël N, Salvator H, Catherinot E, Couderc LJ, Sokol H, Lanternier F, Fouyssac F, Bardet J, Bustamante J, Gougerot-Pocidalo MA, Barlogis V, Masseau A, Durieu I, Lecuit M, Clinical infectious diseases : an official publication o

http://europepmc.org/abstract/med/28362954

View Article
March 2017

A microbial signature for Crohn's disease.

Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C, Gut, 2017, 2017

http://europepmc.org/abstract/med/28179361

View Article
March 2017

European consensus conference on faecal microbiota transplantation in clinical practice.

Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Gut, 2017, 2017

http://europepmc.org/abstract/med/28087657

View Article
January 2017

Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses.

Rossi O, van Berkel LA, Chain F, Tanweer Khan M, Taverne N, Sokol H, Duncan SH, Flint HJ, Harmsen HJ, Langella P, Samsom JN, Wells JM, Scientific reports, 2016, vol. 6, pp. 18507

http://europepmc.org/abstract/med/26725514

View Article
2016

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice.

Martín R, Laval L, Chain F, Miquel S, Natividad J, Cherbuy C, Sokol H, Verdu EF, van Hylckama Vlieg J, Bermudez-Humaran LG, Smokvina T, Langella P, Frontiers in microbiology, 2016, vol. 7, pp. 608, 2016

http://europepmc.org/abstract/med/27199937

View Article
2016

Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.

Miquel S, Martín R, Lashermes A, Gillet M, Meleine M, Gelot A, Eschalier A, Ardid D, Bermúdez-Humarán LG, Sokol H, Thomas M, Theodorou V, Langella P, Carvalho FA, Scientific reports, 2016, vol. 6, pp. 19399

http://europepmc.org/abstract/med/26775847

View Article
2016

Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

Fumery M, Seksik P, Auzolle C, Munoz-Bongrand N, Gornet JM, Boschetti G, Cotte E, Buisson A, Dubois A, Pariente B, Zerbib P, Chafai N, Stefanescu C, Panis Y, Marteau P, Pautrat K, Sabbagh C, Filippi J, Chevrier M, Houze P, The American journal of gastroenterology, 2016, 2016

http://europepmc.org/abstract/med/27958285

View Article
2016

Mature CD8 T-cell clonal expansion in the oral cavity and digestive tract: a severe lymphoid malignancy that mimics Crohn's disease.

Clin Case Rep 2016 12 11;4(12):1088-1090. Epub 2016 Oct 11.

UPMC Univ Paris 06ParisFrance; Service de Gastro-EntérologieHôpital Saint-Antoine, AP-HPParisFrance.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccr3.668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134143PMC
December 2016
28 Reads

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.

Cosnes J, Sokol H, Bourrier A, Nion-Larmurier I, Wisniewski A, Landman C, Marteau P, Beaugerie L, Perez K, Seksik P, Alimentary pharmacology & therapeutics, 2016, vol. 44, no. 10, pp. 1102-1113, 2016

http://europepmc.org/abstract/med/27666569

View Article
December 2016

[CARD9 is involved in the recovery of colitis by promoting the production of AhR ligands by the intestinal microbiota].

Med Sci (Paris) 2016 Nov 23;32(11):933-936. Epub 2016 Dec 23.

Sorbonne Université-université P. et M. Curie (UPMC), Paris, France - Inserm, ERL 1157, Avenir team Gut Microbiota and Immunity, Paris, France - CNRS, UMR 7203, Paris, France - Laboratoire de BioMolécules, CHU Saint-Antoine 27, rue de Chaligny, Paris, France - Micalis Institute, INRA, AgroParisTech, université Paris-Saclay, 78350 Jouy-en-Josas, France - Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, France - Département de gastroentérologie, hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, université P. et M. Curie (UPMC), 184, rue du faubourg Saint-Antoine, 75571 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20163211007DOI Listing
November 2016
14 Reads
1 Citation
0.520 Impact Factor

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Fischer M, Kao D, Kelly C, Kuchipudi A, Jafri SM, Blumenkehl M, Rex D, Mellow M, Kaur N, Sokol H, Cook G, Hamilton MJ, Phelps E, Sipe B, Xu H, Allegretti JR, Inflammatory bowel diseases, 2016, vol. 22, no. 10, pp. 2402-2409, 2016

http://europepmc.org/abstract/med/27580384

View Article
October 2016

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Immunity 2016 10 4;45(4):931-943. Epub 2016 Oct 4.

Institut de Cancérologie Gustave Roussy Cancer Campus (GRCC), 114 rue Edouard Vaillant, Villejuif, 94805, France; Institut National de la Santé Et de la Recherche Medicale (INSERM), U1015, GRCC, Villejuif, 94805, France; University of Paris-Saclay, Kremlin Bicêtre, 94270, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, 94805, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2016.09.009DOI Listing
October 2016
173 Reads
31 Citations
21.561 Impact Factor

Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Inflamm Bowel Dis 2016 10;22(10):2402-9

*Indiana University, Indianapolis, Indiana; †University of Alberta, Edmonton, Alberta, Canada; ‡Lifespan Women's Medicine Collaborative and the Alpert Medical School of Brown University, Providence, Rhode Island; §Henry Ford Hospital, Detroit, Michigan; ‖Integris Digestive Health Center, Oklahoma City, Oklahoma; ¶Hospital Saint-Antoine, Paris, France; **Brigham and Women's Hospital, Boston Massachusetts; and ††Community Hospital, Anderson, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000908DOI Listing
October 2016
65 Reads
19 Citations
4.464 Impact Factor

Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.

Dior M, Delagrèverie H, Duboc H, Jouet P, Coffin B, Brot L, Humbert L, Trugnan G, Seksik P, Sokol H, Rainteau D, Sabate JM, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 2016, vol. 28, no. 9, pp. 1330-1340, 2016

http://europepmc.org/abstract/med/27060367

View Article
October 2016

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects.

Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CP, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, Langella P, Sokol H, Kroemer G, Enot D, Roux A, Immunity, 2016, 2016

http://europepmc.org/abstract/med/27717798

View Article
October 2016

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands.

Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, Bridonneau C, Jegou S, Hoffmann TW, Natividad JM, Brot L, Taleb S, Couturier-Maillard A, Nion-Larmurier I, Merabtene F, Seksik P, Bourrier A, Cosnes J, Ryffel B, Beaugerie L, Nature medicine, 2016, vol. 22, no. 6, pp. 598-605, 2016

http://europepmc.org/abstract/med/27158904

View Article
July 2016

Bifidobacterium animalis ssp. lactis CNCM-I2494 Restores Gut Barrier Permeability in Chronically Low-Grade Inflamed Mice.

Front Microbiol 2016 6;7:608. Epub 2016 May 6.

Commensal and Probiotics-Host Interactions Laboratory, Micalis Institute, Institut National de la Recherche Agronomique, AgroParisTech, Université Paris-Saclay Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fmicb.2016.00608DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858658PMC
May 2016
91 Reads
1 Citation
3.941 Impact Factor

The presence of the anti-inflammatory protein MAM, from Faecalibacterium prausnitzii, in the intestinal ecosystem.

Gut 2016 May 15;65(5):882. Epub 2015 Dec 15.

Service de Gastroentérologie et nutrition, APHP, Hôpital Saint Antoine, Paris, France Sorbonne Universités, UPMC Université Paris 6, Paris, France Inflammation-Immunopathology-Biotherapy Department (DHU i2B), INSERM-ERL 1157, Paris, France UMR 7203 Laboratoire des Biomolécules, UPMC/CNRS/ENS, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2015-311094DOI Listing
May 2016
26 Reads
3 Citations
14.660 Impact Factor

Toward Rational Donor Selection in Faecal Microbiota Transplantation for IBD.

Authors:
Sokol H

Sokol H, Journal of Crohn's & colitis, 2016, vol. 10, no. 4, pp. 375-376

http://europepmc.org/abstract/med/26746170

View Article
May 2016

Toward Rational Donor Selection in Faecal Microbiota Transplantation for IBD.

Authors:
Harry Sokol

J Crohns Colitis 2016 Apr 7;10(4):375-6. Epub 2016 Jan 7.

Avenir Team Gut Microbiota and Immunity, UMR 7203, Saint-Antoine Hospital, Paris, France, INRA, UMR1319 Micalis & AgroParisTech, Jouy en Josas, France, and Department of Gastroenterology, Saint Antoine Hospital, AP-HP, UPMC Univ Paris 06, France; French Group of Faecal Microbiota Transplantation [GFTF]

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjw005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946769PMC
April 2016
11 Reads
2 Citations
6.234 Impact Factor

Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptoms.

Georgin-Lavialle S, Launay JM, Côté F, Soucié E, Soria A, Damaj G, Moura DS, Canioni D, Hanssens K, Chandesris MO, Barète S, Dubreuil P, Lortholary O, Hermine O, Sokol H, Allergy, 2016, vol. 71, no. 3, pp. 416-420

http://europepmc.org/abstract/med/26841279

View Article
March 2016

Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients.

J Crohns Colitis 2016 Mar 15;10(3):296-305. Epub 2015 Nov 15.

Equipe Avenir Gut Microbiota and Immunity, U1157/UMR7203, Faculté de Médecine Saint-Antoine, Université Pierre et Marie Curie, Paris, France Inflammation-Immunopathology-Biotherapy Département, Hospitalo-Universitaire, Paris, France INRA, UMR1319 MICALIS, Jouy en Josas, France AgroParisTech, UMR1319 MICALIS, Jouy en Josas, France Service de Gastroentérologie et Nutrition, Assistance Publique Hôpitaux de Paris et Université Paris6, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ecco-jcc/jjv209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957473PMC
March 2016
68 Reads
22 Citations
6.234 Impact Factor

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.

Dig Liver Dis 2016 Mar 7;48(3):242-7. Epub 2015 Sep 7.

Gastroenterology and Nutrition Department, AP-HP, Saint-Antoine Hospital and UPMC Paris 06 University, GRC n°03, SUVIMIC, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2015.08.017DOI Listing
March 2016
127 Reads
10 Citations
2.963 Impact Factor

Fungal microbiota dysbiosis in IBD.

Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L, Gut, 2016

http://europepmc.org/abstract/med/26843508

View Article
March 2016

Effectiveness and Safety of Vedolizumab Induction Therapy for Patients with Inflammatory Bowel Disease.

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Gagniere C, Vuitton L, Clinical gastroenterology and hepatology : the official clinical pra

http://europepmc.org/abstract/med/26917043

View Article
March 2016

Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.

Miquel S, Leclerc M, Martin R, Chain F, Lenoir M, Raguideau S, Hudault S, Bridonneau C, Northen T, Bowen B, Bermúdez-Humarán LG, Sokol H, Thomas M, Langella P, mBio, 2015, vol. 6, no. 2

http://europepmc.org/abstract/med/25900655

View Article
2015

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

Martín R, Miquel S, Chain F, Natividad JM, Jury J, Lu J, Sokol H, Theodorou V, Bercik P, Verdu EF, Langella P, Bermúdez-Humarán LG, BMC microbiology, 2015, vol. 15, pp. 67

http://europepmc.org/abstract/med/25888448

View Article
2015

Inflammatory bowel disease after allogeneic stem cell transplantation.

Boussen I, Sokol H, Aractingi S, Georges O, Hoyeau-Idrissi N, Hugot JP, Mohty M, Rubio MT, Bone marrow transplantation, 2015, vol. 50, no. 10, pp. 1365-1366

http://europepmc.org/abstract/med/26052914

View Article
October 2015

Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.

Metghalchi S, Ponnuswamy P, Simon T, Haddad Y, Laurans L, Clément M, Dalloz M, Romain M, Esposito B, Koropoulis V, Lamas B, Paul JL, Cottin Y, Kotti S, Bruneval P, Callebert J, den Ruijter H, Launay JM, Danchin N, Sokol H, Cell metabolism, 2015, vol. 22, no. 3, pp. 460-471

http://europepmc.org/abstract/med/26235422

View Article
October 2015

Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.

Sokol H, Galperine T, Kapel N, Bourlioux P, Seksik P, Barbut F, Scanzi J, Chast F, Batista R, Joly F, Joly AC, Collignon A, Guery B, Beaugerie L, French Group of Faecal microbiota Transplantation (FGFT), Alric L, Aucouturier JP, Amiot A, Barbut F, Batista R, Digestive and liver disease : official jo

http://europepmc.org/abstract/med/26433619

View Article
October 2015

Changes in the Lemann Index Values During the First Years of Crohn's Disease.

Gilletta C, Lewin M, Bourrier A, Nion-Larmurier I, Rajca S, Beaugerie L, Sokol H, Pariente B, Seksik P, Cosnes J, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2015, vol. 13, no. 9, pp. 1633-40.e3

http://europepmc.org/abstract/med/25766650

View Article
October 2015

Indoleamine 2,3-Dioxygenase Fine-Tunes Immune Homeostasis in Atherosclerosis and Colitis through Repression of Interleukin-10 Production.

Cell Metab 2015 Sep 30;22(3):460-71. Epub 2015 Jul 30.

Institut National de la Santé et de la Recherche Médicale (Inserm), Unit 970, Paris Cardiovascular Research Center, and Université Paris-Descartes, Paris, France; Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmet.2015.07.004DOI Listing
September 2015
89 Reads
13 Citations
17.570 Impact Factor

Probiotics and antibiotics in IBD.

Authors:
Harry Sokol

Dig Dis 2014 17;32 Suppl 1:10-7. Epub 2014 Dec 17.

Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris and Paris VI University, Sorbonne Universités - UPMC Univ Paris 06, INSERM ERL 1157, Avenir Team Gut Microbiota and Immunity, CNRS UMR 7203 LBM CHU Saint-Antoine, and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Paris, and INRA, UMR1319 Micalis, Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000367820DOI Listing
September 2015
33 Reads
13 Citations
1.832 Impact Factor

Changes in the Lémann Index Values During the First Years of Crohn's Disease.

Clin Gastroenterol Hepatol 2015 Sep 10;13(9):1633-40.e3. Epub 2015 Mar 10.

Department of Gastroenterology, Saint Antoine Hospital, Paris, France; Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris and Paris VI University, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.02.041DOI Listing
September 2015
35 Reads
4 Citations
7.900 Impact Factor

Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons.

Dig Dis 2015 14;33 Suppl 1:105-112. Epub 2015 Sep 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000437104DOI Listing
September 2015
4 Reads
5 Citations
1.832 Impact Factor

Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice.

Hoffmann TW, Pham HP, Bridonneau C, Aubry C, Lamas B, Martin-Gallausiaux C, Moroldo M, Rainteau D, Lapaque N, Six A, Richard ML, Fargier E, Le Guern ME, Langella P, Sokol H, The ISME journal, 2015

http://europepmc.org/abstract/med/26218241

View Article
July 2015

Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease.

Quévrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, Miquel S, Carlier L, Bermúdez-Humarán LG, Pigneur B, Lequin O, Kharrat P, Thomas G, Rainteau D, Aubry C, Breyner N, Afonso C, Lavielle S, Grill JP, Chassaing G, Gut, 2015

http://europepmc.org/abstract/med/26045134

View Article
July 2015

An image-based genetic assay identifies genes in T1D susceptibility loci controlling cellular antiviral immunity in mouse.

PLoS One 2014 30;9(9):e108777. Epub 2014 Sep 30.

Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts, United States of America; Center for Computational and Integrative Biology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America; Gastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0108777PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182575PMC
June 2015
37 Reads
3 Citations
3.234 Impact Factor

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Hum Vaccin Immunother 2014 14;10(6):1611-21. Epub 2014 Apr 14.

INRA; Commensal and Probiotics-Host Interactions Laboratory; UMR 1319 Micalis; Jouy-en-Josas, France; AgroParisTech; UMR1319 Micalis; Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.28549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396252PMC
June 2015
22 Reads
6 Citations
2.131 Impact Factor

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

Gagniere C, Beaugerie L, Pariente B, Seksik P, Amiot A, Abitbol V, Allez M, Cosnes J, Sokol H, Journal of Crohn's & colitis, 2015, vol. 9, no. 4, pp. 349-355

http://europepmc.org/abstract/med/25547977

View Article
May 2015

Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease.

Richard ML, Lamas B, Liguori G, Hoffmann TW, Sokol H, Inflammatory bowel diseases, 2015, vol. 21, no. 3, pp. 656-665

http://europepmc.org/abstract/med/25545379

View Article
March 2015

Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease.

Inflamm Bowel Dis 2015 Mar;21(3):656-65

*INRA, UMR1319 Micalis, Jouy en Josas, France; †AgroParisTech, UMR Micalis, Jouy en Josas, France; ‡Inflammation-Immunopathology-Biotherapy Department, DHU i2B, Paris, France; §Sorbonne Universités - UPMC Univ Paris 06, INSERM ERL 1157, Avenir Team Gut Microbiota and Immunity, Paris, France; ‖Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; and ¶Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris and Paris VI University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000261DOI Listing
March 2015
28 Reads
19 Citations
4.464 Impact Factor

Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.

BMC Microbiol 2015 Mar 21;15:67. Epub 2015 Mar 21.

INRA, Commensal and Probiotics-Host Interactions Laboratory, UMR 1319 Micalis, F-78350, Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12866-015-0400-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391109PMC
March 2015
39 Reads
30 Citations
2.730 Impact Factor

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Gut Microbes 2014 Mar-Apr;5(2):146-51. Epub 2014 Jan 22.

INRA; Commensal and Probiotics-Host Interactions Laboratory; UMR 1319 Micalis; Jouy-en-Josas, France; AgroParisTech; UMR1319 Micalis; Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/gmic.27651DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063839PMC
February 2015
13 Reads
22 Citations

Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.

Juillerat P, Sokol H, Froehlich F, Yajnik V, Beaugerie L, Lucci M, Burnand B, Macpherson AJ, Cosnes J, Korzenik JR, Inflammatory bowel diseases, 2015, vol. 21, no. 1, pp. 60-70

http://europepmc.org/abstract/med/25517594

View Article
January 2015

Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.

Inflamm Bowel Dis 2015 Jan;21(1):60-70

*MGH Crohn's and Colitis Center, Department of Gastroenterology and Hepatology, Massachusetts General Hospital, Boston, Massachusetts; †Department of Gastroenterology, Clinic for Visceral Surgery and Medicine, Inselspital, Bern University Hospital, Bern, Switzerland; ‡Department of Gastroenterology and Nutrition, Saint-Antoine Hospital, Pierre et Marie Curie-Paris 6 University, Paris, France; §Healthcare Evaluation Unit, Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland; ‖Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland; and ¶Department of Gastroenterology, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000225DOI Listing
January 2015
55 Reads
2 Citations
4.464 Impact Factor

Probiotics and antibiotics in IBD.

Authors:
Sokol H

Sokol H, Digestive diseases (Basel, Switzerland), 2014, vol. 32 Suppl 1, pp. 10-17

http://europepmc.org/abstract/med/25531348

View Article
2014

Impact of probiotics on risk factors for cardiovascular diseases. A review.

Ebel B, Lemetais G, Beney L, Cachon R, Sokol H, Langella P, Gervais P, Critical reviews in food science and nutrition, 2014, vol. 54, no. 2, pp. 175-189

http://europepmc.org/abstract/med/24188267

View Article
2014

Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia.

Kumar V, Cheng SC, Johnson MD, Smeekens SP, Wojtowicz A, Giamarellos-Bourboulis E, Karjalainen J, Franke L, Withoff S, Plantinga TS, van de Veerdonk FL, van der Meer JW, Joosten LA, Sokol H, Bauer H, Herrmann BG, Bochud PY, Marchetti O, Perfect JR, Xavier RJ, Nature communications, 2014, vol. 5, pp.

http://europepmc.org/abstract/med/25197941

View Article
2014

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.

Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG, Human vaccines & immunotherapeutics, 2014, vol. 10, no. 6, pp. 1611-1621

http://europepmc.org/abstract/med/24732667

View Article
2014

Ecology and metabolism of the beneficial intestinal commensal bacterium Faecalibacterium prausnitzii.

Miquel S, Martín R, Bridonneau C, Robert V, Sokol H, Bermúdez-Humarán LG, Thomas M, Langella P, Gut microbes, 2014, vol. 5, no. 2, pp. 146-151

http://europepmc.org/abstract/med/24637606

View Article
2014

Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

Regnault H, Bourrier A, Lalande V, Nion-Larmurier I, Sokol H, Seksik P, Barbut F, Cosnes J, Beaugerie L, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, vol. 46, no. 12, pp. 1086-1092

http://europepmc.org/abstract/med/25294795

View Article
2014

Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

Dig Liver Dis 2014 Dec 5;46(12):1086-92. Epub 2014 Oct 5.

Department of Gastroenterology, APHP, Saint-Antoine Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2014.09.003DOI Listing
December 2014
111 Reads
8 Citations
2.963 Impact Factor

Bacterial protein signals are associated with Crohn's disease.

Juste C, Kreil DP, Beauvallet C, Guillot A, Vaca S, Carapito C, Mondot S, Sykacek P, Sokol H, Blon F, Lepercq P, Levenez F, Valot B, Carré W, Loux V, Pons N, David O, Schaeffer B, Lepage P, Martin P, Gut, 2014, vol. 63, no. 10, pp. 1566-1577

http://europepmc.org/abstract/med/24436141

View Article
October 2014

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Beaugerie L, Carrat F, Colombel JF, Bouvier AM, Sokol H, Babouri A, Carbonnel F, Laharie D, Faucheron JL, Simon T, de Gramont A, Peyrin-Biroulet L, CESAME Study Group, Gut, 2014, vol. 63, no. 9, pp. 1416-1423

http://europepmc.org/abstract/med/24162591

View Article
October 2014

Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer.

Gut 2014 Sep 25;63(9):1416-23. Epub 2013 Oct 25.

Inserm U954 and Department of Hepato-Gastroenterology, University Hospital of Nancy, Université Henri Poincaré 1, Vandoeuvre-lès-Nancy, Nancy, France.

View Article

Download full-text PDF

Source
http://gut.bmj.com/content/63/9/1416.full.pdf
Web Search
http://gut.bmj.com/cgi/doi/10.1136/gutjnl-2013-305763
Publisher Site
http://dx.doi.org/10.1136/gutjnl-2013-305763DOI Listing
September 2014
36 Reads
15 Citations
14.660 Impact Factor

Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease.

Rajca S, Seksik P, Bourrier A, Sokol H, Nion-Larmurier I, Beaugerie L, Cosnes J, Journal of Crohn's & colitis, 2014, vol. 8, no. 8, pp. 819-824

http://europepmc.org/abstract/med/24439392

View Article
August 2014

Crohn's disease of the vulva.

Barret M, de Parades V, Battistella M, Sokol H, Lemarchand N, Marteau P, Journal of Crohn's & colitis, 2014, vol. 8, no. 7, pp. 563-570

http://europepmc.org/abstract/med/24252167

View Article
July 2014

Complications and surgery in the inflammatory bowel diseases biological era.

Sokol H, Seksik P, Cosnes J, Current opinion in gastroenterology, 2014, vol. 30, no. 4, pp. 378-384

http://europepmc.org/abstract/med/24840000

View Article
July 2014

Beneficial effects of exclusive enteral nutrition in Crohn's disease are not mediated by Faecalibacterium prausnitzii.

Inflamm Bowel Dis 2014 Jul;20(7):E18

*Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris and Paris VI University, Paris, France †AVENIR Team, Gut Microbiota and Immunity, INSERM U1057/UMR CNRS 7203, Université Pierre et Marie Curie 6, Paris, France ‡Commensal and Probiotics-Host Interactions Laboratory, UMR 1319 Micalis, Jouy-en-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000071DOI Listing
July 2014
2 Reads
1 Citation
4.464 Impact Factor

Complications and surgery in the inflammatory bowel diseases biological era.

Curr Opin Gastroenterol 2014 Jul;30(4):378-84

Service de Gastroentérologie et Nutrition, Hôpital St-Antoine, et Université Paris VI, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOG.0000000000000078DOI Listing
July 2014
6 Reads
4 Citations
4.290 Impact Factor

Crohn's disease of the vulva.

J Crohns Colitis 2014 Jul 16;8(7):563-70. Epub 2013 Nov 16.

Department of Gastroenterology and Digestive Surgery, Hôpital Lariboisière, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2013.10.009DOI Listing
July 2014
54 Reads
3 Citations
6.234 Impact Factor

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.

Rajca S, Grondin V, Louis E, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Paintaud G, Piver E, Allez M, Mary JY, Sokol H, Inflammatory bowel diseases, 2014, vol. 20, no. 6, pp. 978-986

http://europepmc.org/abstract/med/24788220

View Article
July 2014

Impact of probiotics on risk factors for cardiovascular diseases. A review.

Crit Rev Food Sci Nutr 2014 ;54(2):175-89

a Unité Procédés Alimentaires et Microbiologiques, UMR A 02.102, AgroSup Dijon/Université de Bourgogne , 1 esplanade Erasme , Dijon , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10408398.2011.579361DOI Listing
June 2014
31 Reads
20 Citations
5.180 Impact Factor

Alterations in the intestinal microbiome (dysbiosis) as a predictor of relapse after infliximab withdrawal in Crohn's disease.

Inflamm Bowel Dis 2014 Jun;20(6):978-86

1Sorbonne Universités - UPMC Univ Paris 06, INSERM ERL 1157, CNRS UMR 7203 LBM and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), CHU Saint-Antoine, Paris, France; 2Centre Hospitalier Universitaire de Liège, Liège, Belgium; 3Université Lille Nord de France and CHRU Lille, Lille, France; 4Hôpital Nord, Centre d'investigation clinique Marseille Nord, Université Méditerranée, Marseille, France; 5INSERM U853, Hôpital Beaujon, Université Paris Diderot, Paris, Clichy, France; 6Université Bordeaux, Bordeaux, France; 7Hôpital Nord, Amiens, France; 8Hôpital Henri Mondor, Créteil, France; 9Hôpital Trousseau, Tours, France; 10Hôpital Saint-Eloi, Montpellier, France; 11Hôtel Dieu, Nantes, France; 12Hôpital Charles Nicolle, Université de Rouen, Rouen, France; 13Hôpital Européen Georges Pompidou, Paris, France; 14University of Ghent, Ghent, Belgium; 15Université François Rabelais de Tours, Tours, France; 16Hôpital Saint-Louis, Université Paris Diderot, Paris, France; 17INSERM U717, Biostatistics and clinical epidemiology, Université Paris Diderot, Paris, France; and 18Icahn Medical School of Medicine at Mount Sinai, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MIB.0000000000000036DOI Listing
June 2014
105 Reads
22 Citations
4.464 Impact Factor

[Causes and differential diagnosis of flush].

Lafont E, Sokol H, Sarre-Annweiler ME, Lecornet-Sokol E, Barete S, Hermine O, Pouchot J, Georgin-Lavialle S, La Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne, 2014, vol. 35, no. 5, pp. 303-309

http://europepmc.org/abstract/med/24080240

View Article
May 2014

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.

Delvincourt M, Lopez A, Pillet S, Bourrier A, Seksik P, Cosnes J, Carrat F, Gozlan J, Beaugerie L, Roblin X, Peyrin-Biroulet L, Sokol H, Alimentary pharmacology & therapeutics, 2014, vol. 39, no. 7, pp. 712-720

http://europepmc.org/abstract/med/24506221

View Article
May 2014

CD4CD8αα lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease.

Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quévrain E, Bridonneau C, Preisser L, Asehnoune K, Labarrière N, Altare F, Sokol H, Jotereau F, PLoS biology, 2014, vol. 12, no. 4, pp. e1001833

http://europepmc.org/abstract/med/24714093

View Article
May 2014

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.

Martín R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, Verdu EF, Bercik P, Bermúdez-Humarán LG, Langella P, Inflammatory bowel diseases, 2014, vol. 20, no. 3, pp. 417-430

http://europepmc.org/abstract/med/24418903

View Article
March 2014

The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models.

Inflamm Bowel Dis 2014 Mar;20(3):417-30

*INRA, Commensal and Probiotics-Host Interactions Laboratory, UMR 1319 Micalis, Jouy-en-Josas, France; †AgroParisTech, UMR 1319 Micalis, Jouy-en-Josas, France; ‡Farncombe Family Digestive Health Research Institute, Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada; §Department of Gastroenterology and Nutrition, AP-HP, Hôpital Saint-Antoine and UPMC University of Paris, Paris, France; and ‖Equipe AVENIR Gut Microbiota and Immunity, INSERM U1057/UMR CNRS 7203, Université Pierre et Marie Curie 6, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.MIB.0000440815.76627.64DOI Listing
March 2014
27 Reads
36 Citations
4.464 Impact Factor

Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

Magro F, Peyrin-Biroulet L, Sokol H, Aldeger X, Costa A, Higgins PD, Joyce JC, Katsanos KH, Lopez A, de Xaxars TM, Toader E, Beaugerie L, Journal of Crohn's & colitis, 2014, vol. 8, no. 1, pp. 31-44

http://europepmc.org/abstract/med/23721759

View Article
January 2014

Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).

J Crohns Colitis 2014 Jan 27;8(1):31-44. Epub 2013 May 27.

Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine F-75012 and ERL 1057 INSERM/UMRS 7203, UPMC Univ Paris 06F-75005, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2013.04.006DOI Listing
January 2014
39 Reads
19 Citations
6.234 Impact Factor

[A colourful villous atrophy].

Augustin J, Hoyeau N, Sokol H, Fléjou JF, Svrcek M, Annales de pathologie, 2013, vol. 33, no. 6, pp. 418-420

http://europepmc.org/abstract/med/24331726

View Article
2013

[A colourful villous atrophy].

Ann Pathol 2013 Dec 21;33(6):418-20. Epub 2013 Nov 21.

Service d'anatomie et cytologie pathologiques, hôpital Saint-Antoine, 184, rue du Faubourg-Saint-Antoine, 75012 Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2013.10.019DOI Listing
December 2013
20 Reads
0.291 Impact Factor

Gastrointestinal manifestations in mastocytosis: a study of 83 patients.

Sokol H, Georgin-Lavialle S, Canioni D, Barete S, Damaj G, Soucie E, Bruneau J, Chandesris MO, Suarez F, Launay JM, Aouba A, Grandpeix-Guyodo C, Lanternier F, Grosbois B, de Gennes C, Cathébras P, Fain O, Hoyeau-Idrissi N, Dubreuil P, Lortholary O, The Journal of allergy and clinical immunology, 201

http://europepmc.org/abstract/med/23890756

View Article
October 2013

Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series.

Noel N, Mahlaoui N, Blanche S, Suarez F, Coignard-Biehler H, Durieu I, Godeberge P, Sokol H, Catherinot E, Poiree S, Chapdelaine H, Dunogue B, Bodemer C, Lecuit M, Fischer A, Lortholary O, Hermine O, The Journal of allergy and clinical immunology, 2013, vol. 132, no. 4, pp. 997-1000.e1-4

http://europepmc.org/abstract/med/23791514

View Article
October 2013

Gastrointestinal manifestations in mastocytosis: a study of 83 patients.

J Allergy Clin Immunol 2013 Oct 26;132(4):866-73.e1-3. Epub 2013 Jul 26.

Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine, AP-HP, Université Pierre et Marie Curie-Paris 6, Paris, France; Equipe AVENIR, Laboratoire INSERM U1057/UMR CNRS 7203, Université Pierre et Marie Curie 6, Paris, France; Equipe Interactions des bactéries commensales et probiotiques avec l'hôte, MICALIS, INRA, Jouy en Josas, France; Centre de Référence des Mastocytoses, Faculté de Médecine et AP-HP Necker-Enfants Malades, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2013.05.026DOI Listing
October 2013
98 Reads
6 Citations
11.480 Impact Factor

Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: a retrospective case series.

J Allergy Clin Immunol 2013 Oct 20;132(4):997-1000.e1-4. Epub 2013 Jun 20.

Assistance Publique-Hôpitaux de Paris, CEREDIH, Centre de Référence Déficits Immunitaires Héréditaires, Hôpital Necker-Enfants Malades, Paris, France; Assistance Publique-Hôpitaux de Paris, Service de Maladies Infectieuses et Tropicales, Centre d'Infectiologie Necker Pasteur, Paris, France; Institut Imagine, Université Sorbonne Paris Cité, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaci.2013.04.059DOI Listing
October 2013
37 Reads
3 Citations
11.480 Impact Factor

Decreased lymphatic vessel density is associated with postoperative endoscopic recurrence in Crohn's disease.

Rahier JF, Dubuquoy L, Colombel JF, Jouret-Mourin A, Delos M, Ferrante M, Sokol H, Hertogh GD, Salleron J, Geboes K, Desreumaux P, Inflammatory bowel diseases, 2013, vol. 19, no. 10, pp. 2084-2090

http://europepmc.org/abstract/med/23851640

View Article
October 2013

Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice.

Sokol H, Conway KL, Zhang M, Choi M, Morin B, Cao Z, Villablanca EJ, Li C, Wijmenga C, Yun SH, Shi HN, Xavier RJ, Gastroenterology, 2013, vol. 145, no. 3, pp. 591-601.e3

http://europepmc.org/abstract/med/23732773

View Article
October 2013

Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice.

Gastroenterology 2013 Sep 31;145(3):591-601.e3. Epub 2013 May 31.

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2013.05.047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781941PMC
September 2013
60 Reads
41 Citations
16.720 Impact Factor

Faecalibacterium prausnitzii and human intestinal health.

Miquel S, Martín R, Rossi O, Bermúdez-Humarán LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P, Current opinion in microbiology, 2013, vol. 16, no. 3, pp. 255-261

http://europepmc.org/abstract/med/23831042

View Article
July 2013

Long-term outcome of patients with Crohn's disease who respond to azathioprine.

Camus M, Seksik P, Bourrier A, Nion-Larmurier I, Sokol H, Baumer P, Beaugerie L, Cosnes J, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013, vol. 11, no. 4, pp. 389-394

http://europepmc.org/abstract/med/23142207

View Article
May 2013

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

Duboc H, Rajca S, Rainteau D, Benarous D, Maubert MA, Quervain E, Thomas G, Barbu V, Humbert L, Despras G, Bridonneau C, Dumetz F, Grill JP, Masliah J, Beaugerie L, Cosnes J, Chazouillères O, Poupon R, Wolf C, Mallet JM, Gut, 2013, vol. 62, no. 4, pp. 531-539

http://europepmc.org/abstract/med/22993202

View Article
May 2013

Long-term outcome of patients with Crohn's disease who respond to azathioprine.

Clin Gastroenterol Hepatol 2013 Apr 6;11(4):389-94. Epub 2012 Nov 6.

Department of Gastroenterology, Saint Antoine Hospital, Assistance Publique Hôpitaux de Paris and Paris VI University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2012.10.038DOI Listing
April 2013
28 Reads
8 Citations
7.900 Impact Factor

[Acute infectious diarrhea in adults: epidemiology and management].

Beaugerie L, Sokol H, Presse medicale (Paris, France : 1983), 2013, vol. 42, no. 1, pp. 52-59

http://europepmc.org/abstract/med/23253255

View Article
January 2013

[Acute infectious diarrhea in adults: epidemiology and management].

Presse Med 2013 Jan 17;42(1):52-9. Epub 2012 Dec 17.

AP-HP, hôpital Saint-Antoine, service de gastroentérologie et de nutrition, 75012 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2012.09.014DOI Listing
January 2013
9 Reads
1 Citation
1.173 Impact Factor

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment.

Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C, Genome biology, 2012, vol. 13, no. 9, pp. R79

http://europepmc.org/abstract/med/23013615

View Article
2012

Crosstalk between the hepatologist and the cardiologist: a future place for the lithocholic acid as a coronary atheroma risk factor?

Duboc H, Aelion H, Rainteau D, Rajca S, Sokol H, Humbert L, Farabos D, Coffin B, Weber S, Porcher R, Varenne O, Duboc D, Hepatology (Baltimore, Md.), 2012, vol. 56, no. 6, pp. 2426

http://europepmc.org/abstract/med/22605482

View Article
2012

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Sokol H, Beaugerie L, Maynadié M, Laharie D, Dupas JL, Flourié B, Lerebours E, Peyrin-Biroulet L, Allez M, Simon T, Carrat F, Brousse N, CESAME Study Group, Inflammatory bowel diseases, 2012, vol. 18, no. 11, pp. 2063-2071

http://europepmc.org/abstract/med/22271569

View Article
December 2012

Excess primary intestinal lymphoproliferative disorders in patients with inflammatory bowel disease.

Inflamm Bowel Dis 2012 Nov 23;18(11):2063-71. Epub 2012 Jan 23.

Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine and UPMC University of Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.22889DOI Listing
November 2012
31 Reads
10 Citations
4.464 Impact Factor

p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation.

Conway KL, Goel G, Sokol H, Manocha M, Mizoguchi E, Terhorst C, Bhan AK, Gardet A, Xavier RJ, Journal of immunology (Baltimore, Md. : 1950), 2012, vol. 189, no. 7, pp. 3631-3640

http://europepmc.org/abstract/med/22914050

View Article
October 2012

p40phox expression regulates neutrophil recruitment and function during the resolution phase of intestinal inflammation.

J Immunol 2012 Oct 22;189(7):3631-40. Epub 2012 Aug 22.

Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1103746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3780969PMC
October 2012
18 Reads
17 Citations
4.922 Impact Factor

Factors affecting outcomes in Crohn's disease over 15 years.

Cosnes J, Bourrier A, Nion-Larmurier I, Sokol H, Beaugerie L, Seksik P, Gut, 2012, vol. 61, no. 8, pp. 1140-1145

http://europepmc.org/abstract/med/22387526

View Article
August 2012

Clinical, serological and genetic predictors of inflammatory bowel disease course.

Beaugerie L, Sokol H, World journal of gastroenterology, 2012, vol. 18, no. 29, pp. 3806-3813

http://europepmc.org/abstract/med/22876031

View Article
August 2012

Factors affecting outcomes in Crohn's disease over 15 years.

Gut 2012 Aug 2;61(8):1140-5. Epub 2012 Mar 2.

Gastroenterology & Nutrition Unit St-Antoine Hospital and Pierre-et-Marie Curie University (PARIS VI), APHP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gutjnl-2011-301971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388724PMC
August 2012
62 Reads
11 Citations
14.660 Impact Factor

Clinical, serological and genetic predictors of inflammatory bowel disease course.

World J Gastroenterol 2012 Aug;18(29):3806-13

Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3748/wjg.v18.i29.3806DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413051PMC
August 2012
34 Reads
17 Citations
2.370 Impact Factor

Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.

Duboc H, Rainteau D, Rajca S, Humbert L, Farabos D, Maubert M, Grondin V, Jouet P, Bouhassira D, Seksik P, Sokol H, Coffin B, Sabaté JM, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society, 2012, vol. 24, no. 6, pp. 513-20, e246-7

http://europepmc.org/abstract/med/22356587

View Article
July 2012

Current smoking differentially affects blood mononuclear cells from patients with Crohn's disease and ulcerative colitis: relevance to its adverse role in the disease.

Bergeron V, Grondin V, Rajca S, Maubert MA, Pigneur B, Thomas G, Trugnan G, Beaugerie L, Cosnes J, Masliah J, Sokol H, Seksik P, Bachelet M, Inflammatory bowel diseases, 2012, vol. 18, no. 6, pp. 1101-1111

http://europepmc.org/abstract/med/21987436

View Article
July 2012

Anti-inflammatory properties of dairy lactobacilli.

Santos Rocha C, Lakhdari O, Blottière HM, Blugeon S, Sokol H, Bermúdez-Humarán LG, Azevedo V, Miyoshi A, Doré J, Langella P, Maguin E, van de Guchte M, Inflammatory bowel diseases, 2012, vol. 18, no. 4, pp. 657-666

http://europepmc.org/abstract/med/21837773

View Article
May 2012

Anti-inflammatory properties of dairy lactobacilli.

Inflamm Bowel Dis 2012 Apr 11;18(4):657-66. Epub 2011 Aug 11.

INRA, UMR1319 Micalis, Jouy en Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.21834DOI Listing
April 2012
43 Reads
14 Citations
4.464 Impact Factor

Colorectal neoplasia in PSC-IBD patients: are times changing?

Sokol H, Chazouilleres O, Liver international : official journal of the International Association for the Study of the Liver, 2012, vol. 32, no. 2, pp. 175-176

http://europepmc.org/abstract/med/22226230

View Article
March 2012

Colorectal neoplasia in PSC-IBD patients: are times changing?

Liver Int 2012 Feb;32(2):175-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1478-3231.2011.02671.xDOI Listing
February 2012
4.850 Impact Factor

Candida spp. with acquired echinocandin resistance, France, 2004-2010.

Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O, French Mycoses Study Group, Emerging infectious diseases, 2012, vol. 18, no. 1, pp. 86-90

http://europepmc.org/abstract/med/22257484

View Article
January 2012

Air mass pushing the liver.

Barret M, Coriat R, Beaugerie L, Sokol H, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2011, vol. 43, no. 12, pp. 1025

http://europepmc.org/abstract/med/21752737

View Article
2011

Air mass pushing the liver.

Dig Liver Dis 2011 Dec 12;43(12):1025. Epub 2011 Jul 12.

Gastroenterology Department, Hôpital Saint Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2011.06.005DOI Listing
December 2011
31 Reads
2.963 Impact Factor

Sera from patients with Crohn's disease break bacterial lipopolysaccharide tolerance of human intestinal epithelial cells via MD-2 activity.

Seksik P, Sokol H, Grondin V, Adrie C, Duboc H, Pigneur B, Thomas G, Beaugerie L, Trugnan G, Masliah J, Bachelet M, Innate immunity, 2010, vol. 16, no. 6, pp. 381-390

http://europepmc.org/abstract/med/20351135

View Article
2010

Acute cryptosporidiosis as a cause of sudden recurrence of digestive symptoms in patients with Crohn's disease.

Colussi O, Rouen A, Seksik P, Cosnes J, Beaugerie L, Sokol H, Journal of Crohn's & colitis, 2010, vol. 4, no. 6, pp. 669-670

http://europepmc.org/abstract/med/21122578

View Article
2010

Acute cryptosporidiosis as a cause of sudden recurrence of digestive symptoms in patients with Crohn's disease.

J Crohns Colitis 2010 Dec 23;4(6):669-70. Epub 2010 Jun 23.

Department of Gastroenterology and Nutrition, AP-HP, Hôpital Saint-Antoine F-75012 and UPMC Univ Paris 06 F-75005, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.crohns.2010.05.008DOI Listing
December 2010
4 Reads
2 Citations
6.234 Impact Factor

Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis.

Bergeron V, Vienne A, Sokol H, Seksik P, Nion-Larmurier I, Ruskone-Fourmestraux A, Svrcek M, Beaugerie L, Cosnes J, The American journal of gastroenterology, 2010, vol. 105, no. 11, pp. 2405-2411

http://europepmc.org/abstract/med/20551939

View Article
December 2010

Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice.

Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefèvre F, Gratadoux JJ, Honvo-Hueto E, Chilmonczyk S, Blugeon S, Corthier G, Langella P, Bermúdez-Humarán LG, International journal of food microbiology, 2010, vol. 144, no. 1, pp. 35-41

http://europepmc.org/abstract/med/20452077

View Article
December 2010

Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis.

Am J Gastroenterol 2010 Nov 15;105(11):2405-11. Epub 2010 Jun 15.

Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine et Université Pierre-et-Marie Curie (PARIS VI), Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2010.248DOI Listing
November 2010
38 Reads
6 Citations
10.760 Impact Factor

Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice.

Int J Food Microbiol 2010 Nov 2;144(1):35-41. Epub 2010 Apr 2.

Unité d'Ecologie et de Physiologie du Système Digestif, Domaine de Vilvert, 78352 Jouy-en-Josas cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijfoodmicro.2010.03.037DOI Listing
November 2010
40 Reads
22 Citations
3.082 Impact Factor

Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.

Gut 2010 Oct 29;59(10):1363-8. Epub 2010 Jun 29.

Gastroenterology and Nutrition Department, Saint-Antoine hospital, AP-HP, 184 rue du faubourg Saint Antoine, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/gut.2010.212712DOI Listing
October 2010
37 Reads
26 Citations
14.660 Impact Factor

The intestinal microbiota in inflammatory bowel diseases: time to connect with the host.

Authors:
Sokol H Seksik P

Sokol H, Seksik P, Current opinion in gastroenterology, 2010, vol. 26, no. 4, pp. 327-331

http://europepmc.org/abstract/med/20445446

View Article
July 2010

Gastrointestinal involvement and manifestations in systemic mastocytosis.

Sokol H, Georgin-Lavialle S, Grandpeix-Guyodo C, Canioni D, Barete S, Dubreuil P, Lortholary O, Beaugerie L, Hermine O, Inflammatory bowel diseases, 2010, vol. 16, no. 7, pp. 1247-1253

http://europepmc.org/abstract/med/20162539

View Article
July 2010

Gastrointestinal involvement and manifestations in systemic mastocytosis.

Inflamm Bowel Dis 2010 Jul;16(7):1247-53

Department of Gastroenterology and Nutrition, Saint-Antoine Hospital, Université Paris VI, Faculté de Médecine, Assistance Publique-Hôpitaux de Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.21218DOI Listing
July 2010
37 Reads
7 Citations
4.464 Impact Factor

The intestinal microbiota in inflammatory bowel diseases: time to connect with the host.

Curr Opin Gastroenterol 2010 Jul;26(4):327-31

Gastroenterology and Nutrition Department, Saint Antoine Hospital, Université Pierre et Marie Curie, Paris VI, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOG.0b013e328339536bDOI Listing
July 2010
4 Reads
30 Citations
4.290 Impact Factor

Unilateral carotid granulomatous arteritis and Crohn's disease.

Gobron C, Kaci R, Sokol H, Vahedi K, Lejoyeux P, Guillaud C, Wechsler B, Gray F, Bousser MG, Revue neurologique, 2010, vol. 166, no. 5, pp. 542-546

http://europepmc.org/abstract/med/19945129

View Article
May 2010

Body mass index and disease activity at treatment initiation: potential new predictors of response to azathioprine therapy in IBD.

Inflamm Bowel Dis 2010 Apr;16(4):714-5

Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine, UPMC University of Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.21102DOI Listing
April 2010
3 Reads
4.464 Impact Factor

Current smoking, not duration of remission, delays Crohn's disease relapse following azathioprine withdrawal.

Sokol H, Seksik P, Nion-Larmurier I, Vienne A, Beaugerie L, Cosnes J, Inflammatory bowel diseases, 2010, vol. 16, no. 3, pp. 362-363

http://europepmc.org/abstract/med/19462422

View Article
March 2010

[Acute diarrhea in the adult].

Rev Prat 2010 Mar;60(3):413-8

Service de gastroentérologie et nutrition, Fédération d'hépato-gastroentérologie, hôpital Saint-Antoine, 75571 Paris Cedex 12, France.

View Article

Download full-text PDF

Source
March 2010
6 Reads

Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

Sokol H, Vasquez N, Hoyeau-Idrissi N, Seksik P, Beaugerie L, Lavergne-Slove A, Pochart P, Marteau P, World journal of gastroenterology, 2010, vol. 16, no. 5, pp. 583-587

http://europepmc.org/abstract/med/20128026

View Article
March 2010

Appendicitis, not appendectomy, is protective against ulcerative colitis, both in the general population and first-degree relatives of patients with IBD.

Inflamm Bowel Dis 2010 Feb;16(2):356-7

Department of Gastroenterology, AP-HP Hôpital Saint-Antoine, UPMC University of Paris, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.21064DOI Listing
February 2010
6 Reads
3 Citations
4.460 Impact Factor

Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

World J Gastroenterol 2010 Feb;16(5):583-7

Gastroenterology and Nutrition Department, Saint Antoine Hospital, Pierre et Marie Curie-Paris6 University, AP-HP, 184 rue du Faubourg Saint-Antoine, 75571, Paris, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816270PMC
http://dx.doi.org/10.3748/wjg.v16.i5.583DOI Listing
February 2010
24 Reads
6 Citations
2.370 Impact Factor

The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age.

Mariat D, Firmesse O, Levenez F, Guimarăes V, Sokol H, Doré J, Corthier G, Furet JP, BMC microbiology, 2009, vol. 9, pp. 123

http://europepmc.org/abstract/med/19508720

View Article
2009

Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.

Beaugerie L, Sokol H, Seksik P, Digestive diseases (Basel, Switzerland), 2009, vol. 27, no. 3, pp. 375-381

http://europepmc.org/abstract/med/19786768

View Article
2009

Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye.

Dig Dis 2009 24;27(3):375-81. Epub 2009 Sep 24.

Department of Gastroenterology, Saint-Antoine Hospital, and Pierre et Marie Curie University (UPMC), FR-75571 Paris Cedex 12, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000228577DOI Listing
December 2009
5 Reads
5 Citations
1.832 Impact Factor

Single immunoglobulin infusion can reverse hemodynamic failure associated with severe Clostridium difficile colitis.

Sokol H, Maury E, Seksik P, Cosnes J, Beaugerie L, The American journal of gastroenterology, 2009, vol. 104, no. 10, pp. 2649-2650

http://europepmc.org/abstract/med/19806111

View Article
October 2009

Epstein-Barr virus-associated lymphoproliferation awareness in hemophagocytic syndrome complicating thiopurine treatment for Crohn's disease.

Serrate C, Silva-Moreno M, Dartigues P, Poujol-Robert A, Sokol H, Gorin NC, Coppo P, Inflammatory bowel diseases, 2009, vol. 15, no. 10, pp. 1449-1451

http://europepmc.org/abstract/med/19177429

View Article
October 2009

Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease.

Sokol H, Polin V, Lavergne-Slove A, Panis Y, Treton X, Dray X, Bouhnik Y, Valleur P, Marteau P, Gut, 2009, vol. 58, no. 9, pp. 1218-1225

http://europepmc.org/abstract/med/19625280

View Article
October 2009

Gastrointestinal bleeding diagnosed using video capsule endoscopy. Meckel's diverticulum.

Sokol H, Seksik P, Wendum D, Bellanger J, Parc Y, Cosnes J, Beaugerie L, Gut, 2009, vol. 58, no. 9, pp. 1206, 1290

http://europepmc.org/abstract/med/19671555

View Article
October 2009

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, Cosnes J, Corthier G, Marteau P, Doré J, Inflammatory bowel diseases, 2009, vol. 15, no. 8, pp. 1183-1189

http://europepmc.org/abstract/med/19235886

View Article
August 2009

Toll-like receptor 2 is critical for induction of Reg3 beta expression and intestinal clearance of Yersinia pseudotuberculosis.

Dessein R, Gironella M, Vignal C, Peyrin-Biroulet L, Sokol H, Secher T, Lacas-Gervais S, Gratadoux JJ, Lafont F, Dagorn JC, Ryffel B, Akira S, Langella P, Nùñez G, Sirard JC, Iovanna J, Simonet M, Chamaillard M, Gut, 2009, vol. 58, no. 6, pp. 771-776

http://europepmc.org/abstract/med/19174417

View Article
July 2009

Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?

Marteau P, Sokol H, Dray X, Seksik P, Gastroenterologie clinique et biologique, 2009, vol. 33 Suppl 3, pp. S228-34

http://europepmc.org/abstract/med/20117346

View Article
July 2009

Effects of light smoking consumption on the clinical course of Crohn's disease.

Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L, Cosnes J, Inflammatory bowel diseases, 2009, vol. 15, no. 5, pp. 734-741

http://europepmc.org/abstract/med/19067428

View Article
May 2009

Effects of light smoking consumption on the clinical course of Crohn's disease.

Inflamm Bowel Dis 2009 May;15(5):734-41

Gastroenterology & Nutrition Department, Hôpital Saint-Antoine & Université Pierre et Marie Curie, Paris VI, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20828DOI Listing
May 2009
20 Reads
15 Citations
4.460 Impact Factor

Thalidomide as a treatment for refractory CGD colitis.

Sokol H, Suarez F, Meatchi T, Malamut G, Pocidalo MA, Blanche S, Cellier C, Hermine O, The American journal of gastroenterology, 2009, vol. 104, no. 4, pp. 1069

http://europepmc.org/abstract/med/19293783

View Article
May 2009

Thalidomide as a treatment for refractory CGD colitis.

Am J Gastroenterol 2009 Apr 17;104(4):1069. Epub 2009 Mar 17.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ajg.2009.56DOI Listing
April 2009
17 Reads
10.760 Impact Factor

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottière HM, Doré J, Marteau P, Seksik P, Langella P, Proceedings of the National Academy of Sciences of the United

http://europepmc.org/abstract/med/18936492

View Article
October 2008

Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?

Seksik P, Dray X, Sokol H, Marteau P, Molecular nutrition & food research, 2008, vol. 52, no. 8, pp. 906-912

http://europepmc.org/abstract/med/18384087

View Article
August 2008
1 Read

Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?

Mol Nutr Food Res 2008 Aug;52(8):906-12

AP-HP, Hôpital Saint-Antoine, Gastroenterology and Nutrition Department, University Pierre et Marie Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mnfr.200700147DOI Listing
August 2008
54 Reads
7 Citations
4.600 Impact Factor

Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.

Sokol H, Cosnes J, Chazouilleres O, Beaugerie L, Tiret E, Poupon R, Seksik P, World journal of gastroenterology, 2008, vol. 14, no. 22, pp. 3497-3503

http://europepmc.org/abstract/med/18567077

View Article
July 2008

Analysis of bacterial bowel communities of IBD patients: what has it revealed?

Sokol H, Lay C, Seksik P, Tannock GW, Inflammatory bowel diseases, 2008, vol. 14, no. 6, pp. 858-867

http://europepmc.org/abstract/med/18275077

View Article
July 2008

Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis.

World J Gastroenterol 2008 Jun;14(22):3497-503

Gastroenterology and Nutrition Department, Hospital Saint-Antoine 184, rue du faubourg Saint-Antoine, cedex 12, Paris 75571, France.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716611PMC
http://dx.doi.org/10.3748/wjg.14.3497DOI Listing
June 2008
15 Reads
16 Citations
2.370 Impact Factor

Analysis of bacterial bowel communities of IBD patients: what has it revealed?

Inflamm Bowel Dis 2008 Jun;14(6):858-67

Gastroenterology and Nutrition Unit, Saint-Antoine Hospital, APHP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.20392DOI Listing
June 2008
44 Reads
56 Citations
4.460 Impact Factor

[Chronic intestinal pseudo-obstruction and anti-Hu syndrome: 13 years of follow-up without neoplasia].

Amiot A, Joly F, Messing B, Sokol H, Lavergne-Slove A, Delattre JY, Bouhnik Y, Gastroenterologie clinique et biologique, 2008, vol. 32, no. 1 Pt. 1, pp. 51-55

http://europepmc.org/abstract/med/18341976

View Article
January 2008

Severe isolated myopathic gastroparesis: a case report with pathological findings.

Sokol H, Lavergne-Slove A, Mikol J, Sabate JM, Coffin B, Gut, 2006, vol. 55, no. 11, pp. 1662

http://europepmc.org/abstract/med/17047114

View Article
December 2006

Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.

Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, Pochart P, Doré J, Marteau P, Alimentary pharmacology & therapeutics, 2006, vol. 24 Suppl 3, pp. 11-18

http://europepmc.org/abstract/med/16961738

View Article
October 2006

Renal cortical necrosis related to paraneoplastic antiphospholipid syndrome.

Vigneau C, Daugas E, Maury E, Sokol H, Offenstadt G, Rossert J, Guidet B, American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, vol. 47, no. 6, pp. 1072-1074

http://europepmc.org/abstract/med/16731303

View Article
July 2006

Renal cortical necrosis related to paraneoplastic antiphospholipid syndrome.

Am J Kidney Dis 2006 Jun;47(6):1072-4

Intensive Care Unit, St Antoine Hospital, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2006.02.184DOI Listing
June 2006
8 Reads
5.900 Impact Factor

Specificities of the fecal microbiota in inflammatory bowel disease.

Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, Marteau P, Doré J, Inflammatory bowel diseases, 2006, vol. 12, no. 2, pp. 106-111

http://europepmc.org/abstract/med/16432374

View Article
March 2006

Specificities of the fecal microbiota in inflammatory bowel disease.

Inflamm Bowel Dis 2006 Feb;12(2):106-11

Unité d'Ecologie et Physiologie du Système Digestif, INRA Research Center, Jouy-En-Josas, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.MIB.0000200323.38139.c6DOI Listing
February 2006
24 Reads
85 Citations
4.460 Impact Factor

Biopsy-proven anuric acute tubular necrosis associated with vancomycin and one dose of aminoside.

Sokol H, Vigneau C, Maury E, Guidet B, Offenstadt G, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2004, vol. 19, no. 7, pp. 1921-1922

http://europepmc.org/abstract/med/15199201

View Article
July 2004

Biopsy-proven anuric acute tubular necrosis associated with vancomycin and one dose of aminoside.

Nephrol Dial Transplant 2004 Jul;19(7):1921-2

Service de reanimation medicale, Hopital St Antoine, Paris.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfh170DOI Listing
July 2004
13 Reads
4 Citations
3.580 Impact Factor

Top co-authors

Laurent Beaugerie
Laurent Beaugerie

Saint-Antoine Hospital

33
Philippe Langella
Philippe Langella

Centro de Referencia para Lactobacilos (CERELA-CONICET)

29
Philippe Seksik
Philippe Seksik

Saint-Antoine Hospital

24
Jacques Cosnes
Jacques Cosnes

Saint-Antoine Hospital

18
Bruno Lamas
Bruno Lamas

Université d'Auvergne

12
Mathias L Richard
Mathias L Richard

Assistance Publique Hôpitaux de Paris and Paris VI University

12
Florian Chain
Florian Chain

Université Laval

11
Chantal Bridonneau
Chantal Bridonneau

University of Bologna

11
Isabelle Nion-Larmurier
Isabelle Nion-Larmurier

Saint-Antoine Hospital

10